Video

Using the BARF Scale to Measure Nausea

Author(s):

Elizabeth Davis, B.S.N., RN, CPN

One oncology nurse developed the BARF scale so her young patients could better communicate how they were feeling.

Elizabeth Davis, B.S.N., RN, CPN, an oncology nurse at St. Jude Children’s Research Hospital and finalist of the 2018 Extraordinary Healer Award, explains her BARF scale to measure and more accurately treat patients’ nausea that was implemented hospital-wide.

BARF stands for Baxter Animated Retching Faces, and includes a pictorial scale of images ranging from not nauseated at all to extremely nauseated, that helps children explain to their care teams how they are feeling.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of Dr. Boffa.
Immune Therapy Expands Melanoma Treatment to More Patients
Bladder preservation for bladder cancer requires balancing clinical factors and patient health with a personalized treatment plan.
image of doctor D'Sa
Image of Dr. Eng.
Image of Dr. Tagawa.
Most patients in accredited hospitals had smoking discussions documented, showing key care opportunities and smoking’s impact on treatment outcomes.
Illustration of doctor.
Image of doctor.
Image of man with black hair.
Related Content
Dr. Suresh S. Ramalingam explains that patients with stage 3 lung cancer who undergo chemotherapy and radiation may develop radiation pneumonitis.
May 7th 2025

Managing Lung Inflammation After Chemoradiation and Tagrisso

Dr. Suresh S. Ramalingam
Dr. Suresh S. Ramalingam explains that patients with stage 3 lung cancer who undergo chemotherapy and radiation may develop radiation pneumonitis.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
LUT014 improved rashes in patients with colorectal cancer undergoing anti-EGFR therapy: © stock.adobe.com.
May 1st 2025

BRAF Inhibitor Gel Improves Acne-Like Skin Rashes in Colorectal Cancer

Spencer Feldman
LUT014, a BRAF inhibitor gel, improved acne-like rashes in patients with colorectal cancer undergoing anti-EGFR therapy, according to UCLA researchers.
cancer horizons podcast logo: a white microphone on a blue background
March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
Photo of a doctor and patient speaking over a desk
April 9th 2025

PROSTOX May Predict Urinary Side Effects Post Prostate Cancer Radiation

Alex Biese
A test to identify higher risk of developing urinary side effects after radiation in patients with prostate cancer was confirmed by data from a new study.
Image of people.
April 9th 2025

Early Intervention and Screening Prevents Lymphedema After Cancer

Ryan Scott
Dr. Sheri Yolanda Prentiss discusses lymphedema as a result of cancer treatment and shares resources that exist for patients coping with this condition.